Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Medical Supplies segment is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Others segment is engaged in the manufacture, purchase and sale of chemical products, as well as the management of real estate. On September 18, 2013, together with Philip Morris Investments B.V., the Company acquired all shares of Canada-based pharmaceutical company Medicago Inc., and then made it become a 60%-owned consolidated subsidiary. On April 1, 2014, the Company transferred all shares of a Tochigi-based wholly owned subsidiary to CMIC Holdings Co., Ltd.